We use cookies to make this site work. We'd also like to set optional cookies so we can understand how the site is used and improve it. We will not set optional cookies unless you accept them. You can change your choice at any time from the Cookie settings link in the footer.
Strictly necessary cookies
These cookies are required for the site to work. They store your cookie preferences and keep your session secure. They are exempt from consent under PECR Regulation 6(4) because they are essential to deliver the service you have requested.
Optional cookies
Optional cookies help us understand how the site is used and provide additional features such as analytics, accessibility tools and translation. We will only set them if you accept.
Respiratory Syncytial Virus (RSV)
Respiratory syncytial virus (RSV) is a major respiratory virus that is common over the winter period, typically November to February.
The RSV (Respiratory Syncytial Virus) vaccine is an important preventative measure aimed at protecting those most at risk, particularly adults aged 75 and older, those 65 and over with certain underlying health conditions, and pregnant women.
This vaccine helps reduce the risk of severe respiratory illness by stimulating the immune system to defend against RSV.
We have been inviting these patients via text message and letter and we are staring with the oldest patients first. Due to the volume of patients that we need to invite and the nursing resources available we will be inviting this cohort up until August 2025.
NHS England have been sending out communications reminding patients to book their RSV with their GP surgery, but rest assured we will invite you when it is your ages groups turn and we ask you to only contact the surgery about your RSV when you have received a text or letter from us inviting you to book your appointment.
Published: Feb 27, 2025